financetom
Business
financetom
/
Business
/
China bans imports of Illumina's gene sequencers right after Trump tariff action
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
China bans imports of Illumina's gene sequencers right after Trump tariff action
Mar 3, 2025 10:51 PM

SHANGHAI, March 4 (Reuters) - China announced a ban on

Tuesday on imports of genetic sequencers from U.S. medical

equipment maker Illumina ( ILMN ), just minutes after U.S.

President Donald Trump's additional 10% tariff on Chinese goods

took effect.

The ban is part of a series of measures China announced in

response to the extra U.S. tariffs and comes after Beijing put

Illumina ( ILMN ) on its "unreliable entity" list in February.

China accounts for about 7% of Illumina's ( ILMN ) sales. Gene

sequencers help determine the sequence of DNA or RNA, allowing

scientists to study genetic variations associated with diseases

and diagnose rare genetic conditions.

The ban takes effect from March 4.

China's commerce ministry said in a statement that Illumina ( ILMN )

had suspended normal transactions with Chinese enterprises and

taken discriminatory measures against Chinese enterprises.

Illumina ( ILMN ) did not reply to a request for comment outside of

regular U.S. business hours.

In February, China also put PVH Corp ( PVH ), the holding

company for brands including Calvin Klein and Tommy Hilfiger, on

its unreliable entity list and announced an investigation into

Google as part of a wide range of measures targeting

U.S. businesses.

Companies added to the list can be subject to fines and a

broad range of other sanctions, including a freeze on trade and

revocation of work permits for foreign staff.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bristol-Myers Squibb Reportedly Gets Dismissal of Pomalyst Monopoly Suit
Bristol-Myers Squibb Reportedly Gets Dismissal of Pomalyst Monopoly Suit
Apr 9, 2025
02:28 PM EDT, 04/09/2025 (MT Newswires) -- Bristol-Myers Squibb ( BMY ) won the dismissal of a proposed class-action lawsuit in a federal court accusing it of using anticompetitive tactics to maintain monopoly on its blood cancer drug Pomalyst, multiple media outlets reported Wednesday. US District Judge Edgardo Ramos in New York City said in a 70-page decision that Blue...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Keystone oil pipeline remains shut after spill in North Dakota
Keystone oil pipeline remains shut after spill in North Dakota
Apr 9, 2025
April 9 (Reuters) - The Keystone oil pipeline from Canada to the United States remained shut on Wednesday following an oil spill near Fort Ransom, North Dakota, and return to service plans are being evaluated, its operator South Bow ( SOBO ) said. The 4,327-km (2,689-mile) pipeline, a major conduit for crude oil supply from Alberta to U.S. refineries in...
EXPLAINER-Prescription drugs become a target in Trump's trade war
EXPLAINER-Prescription drugs become a target in Trump's trade war
Apr 9, 2025
LONDON, April 9 (Reuters) - U.S. President Donald Trump late on Tuesday reiterated he would impose tariffs on imports of pharmaceutical products that have long been spared from past trade disputes due to the potential for harm to patients. Trump excluded them from his announcement of sweeping import tariffs last week, but in recent weeks he introduced tariffs on raw...
Copyright 2023-2026 - www.financetom.com All Rights Reserved